Description
BPC-157 500mcg + TB-500 500mcg Blend
Experimental Peptide Blend | Laboratory & Analytical Research
BPC-157 500mcg + TB-500 500mcg Blend is a multi-peptide research formulation combining two experimental peptides in a defined 1mg total peptide blend. The formulation brings together BPC-157 and TB-500, which have been independently investigated in preclinical research involving cellular signaling, vascular biology, cell migration, and tissue-related pathways.
The specific combination should be considered an experimental formulation, as evidence for the combined product is substantially more limited than research on the individual compounds.
Composition
| Peptide | Amount |
|---|---|
| BPC-157 | 500mcg |
| TB-500 | 500mcg |
| Total Peptide Content | 1,000mcg (1mg) |
BPC-157 — 500mcg
BPC-157 is a synthetic 15-amino-acid peptide studied primarily in preclinical research involving cellular signaling, angiogenesis-related pathways, gastrointestinal models, vascular biology, and tissue-response mechanisms.
Research remains predominantly experimental, and findings from laboratory or animal models should not be interpreted as established human therapeutic effects.
TB-500 — 500mcg
TB-500 is a synthetic peptide related to thymosin beta-4 and has been investigated in experimental research involving cell migration, actin-related cellular processes, angiogenesis, and tissue biology.
Research into TB-500 and related thymosin-beta-4 pathways remains largely preclinical, and compound-specific evidence should be distinguished from studies of full-length thymosin beta-4.
Key Research Advantages
Dual-Peptide Research Platform
Combines two experimental peptides in a single defined formulation for comparative laboratory studies.
Complementary Research Areas
BPC-157 and TB-500 have been investigated across overlapping areas of cellular and tissue biology, providing researchers with a convenient multi-peptide research model.
Defined 1mg Formulation
The formulation contains 500mcg of each peptide, providing a clearly specified 1:1 composition.
Comparative Research Utility
The blend may be useful for studying individual compounds versus a combined formulation under controlled experimental conditions.
Analytical Characterization
The formulation can be evaluated for peptide identity, purity, concentration, stability, and other relevant analytical parameters.
Potential Research Areas
Laboratory investigations may include:
- Cellular signaling
- Cell migration
- Angiogenesis-related pathways
- Vascular biology
- Connective-tissue research
- Experimental tissue-response models
- Peptide structure–activity studies
- Comparative peptide research
- Stability and formulation studies
Product Specifications
Product Name: BPC-157 + TB-500 Blend
BPC-157: 500mcg
TB-500: 500mcg
Total Peptide Content: 1,000mcg / 1mg
Ratio: 1:1
Category: Experimental peptide blend
Intended Application: Laboratory and analytical research
Quality & Documentation
For research use, batch-specific documentation should ideally provide:
- Peptide identity
- Individual peptide content
- Purity/assay
- Batch or lot number
- Molecular characterization
- Stability information
- Certificate of Analysis (COA)
- Relevant analytical test results
Important Disclaimer
This product is an experimental peptide formulation intended strictly for laboratory research and analytical purposes. It is not intended for human or veterinary consumption, diagnosis, treatment, prevention, or mitigation of disease.
The biological effects of the combined BPC-157 500mcg + TB-500 500mcg formulation have not been established through adequate clinical studies. Preclinical findings involving either individual peptide should not be presented as proven benefits of the combined product. Researchers should follow applicable laboratory safety procedures and regulatory requirements.
Reviews
There are no reviews yet.